Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.20 -0.24 (-1.17%)
As of: Oct 21, 2026 · 3:31 PM EDT

Acadia Pharmaceuticals (ACAD) Share-based Compensation (2010 - 2026)

Updated

Acadia Pharmaceuticals' Share-based Compensation came in at $16.94 million for Q2 2026, up 18.1% from $14.34 million a year earlier and up 15.3% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Acadia Pharmaceuticals reported Share-based Compensation of $58.05 million, down 6.9% year-over-year; for FY2025, it came in at $52.14 million, down 22.2% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of -9.2% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $67.05 million in FY2024 (+0.9%), $66.42 million in FY2023 (-2.6%), $68.2 million in FY2022 (+7.2%) and $63.62 million in FY2021 (-24.6%).
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q3 2024.
  • Year-over-year, Share-based Compensation has increased for three consecutive quarters, with an average decline of 1.0% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q3 2024 (growth of 41.1%), and the weakest in Q3 2025 (a decline of 49.6%).
  • Business Quant data shows ACAD's Share-based Compensation at $14.7 million (Q1 2026), $13.24 million (Q4 2025) and $13.18 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn 166.00 Mn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn -
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn -
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn 249.00 Mn
10 Acadia Pharmaceuticals 3.47 Bn -8.26 Mn 279.64 Mn 16.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.94 Mn
Mar 31, 2026 14.70 Mn
Dec 31, 2025 13.24 Mn
Sep 30, 2025 13.18 Mn
Jun 30, 2025 14.34 Mn
Mar 31, 2025 11.38 Mn
Dec 31, 2024 10.45 Mn
Sep 30, 2024 26.16 Mn
Jun 30, 2024 15.69 Mn
Mar 31, 2024 14.75 Mn
Dec 31, 2023 18.02 Mn
Sep 30, 2023 18.54 Mn
Jun 30, 2023 15.15 Mn
Mar 31, 2023 14.71 Mn
Dec 31, 2022 14.41 Mn
Sep 30, 2022 18.31 Mn
Jun 30, 2022 20.51 Mn
Mar 31, 2022 14.96 Mn
Dec 31, 2021 12.88 Mn
Sep 30, 2021 15.55 Mn
API Access

Acadia Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ACAD&period=max&api_key=YOUR_API_KEY